SBRT for Head and Neck Cancer: Current Evidence and Landscape in Australia

There is an emerging and evolving role of SBRT for head and cancer in both de novo and recurrent cases. This presentation will provide an overview of the current evidence supporting the use of SBRT for head and neck cancer, along with insights into its adoption and implementation across Australia. Dr. Ng will also share […]
SBRT in the Management of Bladder Cancer

Bladder cancer remains the most common form of urothelial carcinoma, and advances in radiation therapy are reshaping treatment paradigms. Hypofractionation, as part of a trimodal approach, offers a promising strategy for bladder preservation, potentially improving tumor control while minimizing toxicity. Additionally, SBRT has emerged as a valuable tool in the management of oligometastatic urothelial cancer, […]
Is SBRT a Valid Option in the Treatment of Oligometastatic Esophagogastric Cancer? Current Evidence and Future Perspectives

SBRT is an emerging treatment in oligometastatic esophagogastric cancer that can increase disease control and improve survival outcomes. It can have a role in different clinical scenarios , such as oligoprogressive or oligorecurrence disease in combination with systemic therapy. SBRT offers high local control rates, low toxicity profile and potential survival benefits in selected patients […]
The Role of Stereotactic Radiosurgery in the Management of Non Vestibular Cranial Nerves Schwannomas

Schwannomas are benign tumors originating from the nerve sheath of peripheral nerves. The most common intracranial schwannomas arise from the vestibular nerves. Stereotactic radiosurgery (SRS) is a recognized management option for vestibular schwannomas, with multiple publications supporting its use. Schwannomas arising on other cranial nerves are uncommon, and their management is not standardized. This webinar […]
Spine SBRT: approaches, patient selection, and toxicity

In this presentation, I hope to explore various approaches to the delivery of spine SBRT, including the various dose-fractionation schemes used in clinical practice. We will explore various efforts to optimize patient selection for treatment, as well as potential toxicity and predictors of increased likelihood for toxicity.
Rib Fracture following SBRT

Stereotactic body radiation therapy has become a standard of care for patients with early stage lung cancer and thoracic metastases. However, toxicities specific to SBRT continue to emerge with longer follow-up in surviving patients. Rib fractures are a common finding following SBRT to the thorax. Understanding clinical and dosimetric predictors may be of assistance in […]
Toxicities Associated with SRS when used in Combination with Targeted Therapies and Immunotherapies

Targeted therapies and immunotherapies are being increasingly used in the treatment of patients with brain metastases. Radiosurgery is also used frequently for the treatment of brain metastases. This talk seeks to inform the radiosurgery user on the potential interactions between SRS and systemic therapies and discuss options for the management of interactive toxicities.
Rare Complications of Spine SBRT

Spine SBRT has been demonstrated in retrospective and prospective studies to provide excellent local control with a low rate of toxicity. However, neuropathies, myelopathy, esophageal toxicty and myositis have been reported. This webinar will discuss these toxicities and management strategies.
Tratamiento del Temblor de Origen Esencial o Parkinsoniano Mediante Radiocirugia Estereotaxica con Gamma Kinfe

El tremblor esencial (TE) es el trastorno del movimiento mas comun, con una incidencia de aproximadamente el 2,5% de la poblacion. La radiocirugia estereotactica con Gamma Knife es eficaz para controlar el tremblor a pesar de la incapacidad de confirmar el objectivo talamico mediante registro neurofisiologico intraoperatorio. Se ha reportado una mejoria significativa del tremblor […]
Diagnosing and Treating Radiation Necrosis / Adverse Radiation Effect

Radiation necrosis, which is also known as adverse radiation effect, is problematic from a diagnosis and treatment standpoint, though we have more tools now. MRI and CT show similar changes with enhancement and edema, and to date, imaging has been imperfect. Since treatment differs for tumor recurrence and radiation necrosis, accurate diagnosis is necessary. New […]
Radiation Necrosis/ARE: Difficulties with Diagnosis and Treatment

Radiation necrosis is one of the most feared complications of stereotactic radiosurgery. With increasing utilization of stereotactic radiosurgery, the incidence of radiation necrosis is also increasing. Historically, diagnosis had been difficult since surgery or biopsy is not often done and imaging had been imperfect. More recently, however, perfusion MRI has emerged as helpful modality to […]
NEUROCOVID: Neurological Complications of COVID19 and Comments from Italian Experience

The webinar will focus on the increasing evidence of COVID19 as a multiorgan disease and will present in detail the neurological manifestations, so called neurocovid, as they are more and more reported from China and Italy and from other countries with increasing literature on the topic. It will also briefly mention about the issues related […]
Hypofractionated Radiosurgery for Perioptic Lesions

Hypofractionated stereotactic radiosurgery (HFSRS) is getting attention as an alternative to single fraction SRS in the management of larger volumes or of lesion close to organs at risk. SRS treatment of lesions residing in direct contact or in close proximity to the optic pathway remains challenging in order to minimize the risk for radiation induced […]